Dr. Purnendu Chatterjee is the Founder and Chairman of The Chatterjee Group (TCG). Dr. Chatterjee established TCG in 1986 as a global enterprise focusing on technology and knowledge leadership which today has diversified interests in investment banking, real estate, petrochemicals, life sciences and healthcare, hedge fund and wealth management products, outsourcing and technology services including BPO. The Chatterjee Group (TCG) is a private U.S. investment and money management firm, headquartered in New York with over $1 Bn in strategic investments. TCG is one of the largest U.S. foreign direct investors in India and has a sound history of successful investments in technology, telecommunications, real estate and asset creation.

TCG Group of Companies has an Ecosystem model which contains Technology companies, reliable Business Processing Outsourcing companies and world class infrastructure.

The strategic growth areas for The Chatterjee Group in India include life sciences, biotechnology, information technology, hydrocarbons and infrastructure. Some of the notable initiatives include Haldia Petrochemicals project, CA TCG Software (JV with Computer Associates), SkyTech Solutions (JV with United Airlines), Bengal Intelligent Park and Asian Gateway.

Some of Chatterjee Group's strategic investments in the biotechnology sector include Applied Biosystems, Celera Genomics, Sepracor, Lynx Therapeutics, Genomics Collaborative Inc.